Paul Robbins

Title: Paul Robbins: Innovator in Cellular Therapeutics

Introduction

Paul Robbins is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of cellular therapeutics, particularly through his innovative research involving human liver stem cells.

Latest Patents

Robbins holds a patent for "Extracellular vesicles derived from human liver stem cells (HLSCs)." This patent discloses a preparation of extracellular vesicles derived from human liver stem cells, specifically from a non-oval human progenitor cell line that expresses hepatic cell markers. The preparation is capable of reducing the senescence of a population of senescent cells, as measured in a SA-β-galactosidase-based cellular senescence assay. The therapeutic applications of this preparation include the reduction of cellular senescence in vitro or ex vivo, as well as the treatment of diseases related to aging and cellular senescence, such as atherosclerosis and type 2 diabetes mellitus.

Career Highlights

Paul Robbins is associated with Unicyte Ev Ag, where he continues to advance his research in cellular therapies. His work has the potential to impact various age-related conditions, providing innovative solutions to improve health outcomes.

Collaborations

Robbins collaborates with esteemed colleagues in the field, including Giovanni Camussi and Maria Beatriz Herrera Sanchez. Their combined expertise enhances the research and development of therapeutic applications derived from stem cell technology.

Conclusion

Paul Robbins is a pioneering inventor whose work in extracellular vesicles derived from human liver stem cells holds promise for advancing therapeutic strategies against age-related diseases. His contributions to the field of cellular therapeutics are noteworthy and continue to inspire further research.